Dulaglutide and Potential Risks of Pancreatic Cancer and Thyroid Cancer: A Non-Interventional PASS (H9X-MC-B013)

24/11/2021
17/06/2025
EU PAS number:
EUPAS32646
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B013 05 Protocol (a)_Redacted

English (5.12 MB - PDF) View document
Updated protocol

LY2189265 Dulaglutide B013 (e) NI PASS Protocol _Redacted.pdf

First published: 03/04/2025
English (589.53 KB - PDF) View document
Study results
Study report
Other information